Incidences of CVD
CVD (32)
MI (33)
Arrhythmias/ICDs (34)
|
|
↑↑
↓
―
(not impact)
|
|
France
Italy
|
HA for CVD
ACS (35)
AMI (36-38)
New-onset Af (39)
HF (40)
Acute CV events (41)
STEMI (42)
Diabetics & hypertension with STEMI (42)
AHF (43)
ADHF admissions (44)
|
↓↓
|
↓
↓↓
↓
↓(not uniform)
↓47%
↓↓
↓
↓31%
↑11.5% & 9.38%
↓↓
|
↑
|
New Zealand
France
France
India
Italy
Danish
South India
South India
London, UK
South India
|
Diabetes
Glycaemic control (45)
|
|
↓
|
|
|
To ICCU
Overall & CVD causes (46)
All causes
ACS (47)
|
|
↓↓
↓↓35%
↓↓49%
↓↓49%
Women
↓28% Men
↓↓61% NSTEMI
↓↓33% STEMI
|
↑
|
|
Medical Treatment
Prescription rates of CVD & Diabetes (48)
Pharmacy purchases of CV drugs (49)
|
|
↑↑
↑↑
|
|
Germany
Germany
|
PCI procedures
PCI for NSTEMI (50)
Primary PCI for STEMI (51)
Reperfusion of STEMI (52)
|
|
↓↓
↓
a significant lag
|
|
England
England
|
Cardiac Surgery
Adult cardiac surgery (53)
CABG (54)
Life-threatening aortic surgery (55)
|
|
~~~ (volatility)
↓
― (maintained)
|
|
Brazil
UK
|
CVD Care
Acute and chronic CVD care (56)
QOL in T2D (57)
Heart rate (58)
Quality of care for AMI (59)
|
|
↓↓
↓
↓
↑
|
|
India
Australia
China
England & Wales
|
Mortality Rates of CVD
Non-Covid-19 related diseases (60)
CABG (54)
|
|
↓
↑
|
|
Non-Wuhan, China
Brazil
|